Scarica l'app Stockscreener
0.2788
2.92%
-0.0084
Dopo l'orario di chiusura:
.29
0.0112
+4.02%
Oragenics Inc Borsa (OGEN) Ultime notizie
StockNews.com Begins Coverage on Oragenics (NYSE:OGEN) - Defense World
The Oragenics Inc (OGEN) Stock Is Headed for a Correction - US Post News
Digital Risk Inc. Launches Digital Footprint Exposure Assessment Tool to Combat Human Cybersecurity Risks - The Manila Times
Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Australia for Mild Traumatic Brain Injury - Nasdaq
Oragenics, Inc. Submits Investigator’s Brochure for Phase - GlobeNewswire
Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI) - Yahoo Finance UK
Oragenics (NYSE:OGEN) Coverage Initiated by Analysts at StockNews.com - Defense World
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment - The Manila Times
Heritage Distilling Co. Cocoa Bomb Chocolate Whiskey Named 'Best Flavored Whiskey” in the United States at Whisky Magazine's World Whiskies Awards - The Manila Times
Oragenics, Inc. to Present Concussion Treatment Advancements at Emergencies in Medicine Conference - Nasdaq
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, - GlobeNewswire
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health - The Manila Times
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab - The Manila Times
Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, - GlobeNewswire
5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail
Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World
Oragenics, Inc. Announces Partnership with BRAINBox - GlobeNewswire
Oragenics Partners With BRAINBox To Develop Intranasal Therapy For Concussion Treatment - Nasdaq
Irobot Corp (IRBT) Stock: From Low to High in 52 Weeks - The InvestChronicle
Adversity is less terrifying than hope: Oragenics Inc (OGEN) - SETE News
Alkeus Pharmaceuticals Announces Two Presentations of Oral Gildeuretinol Data During the 48th Annual Meeting of the Macula Society Being Held February 12-15, 2025 - The Manila Times
Oragenics, Inc. Partners with BRAINBox Solutions to Develop Innovative Intranasal Therapy for Concussion Management - Nasdaq
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment - Yahoo Finance
Press Telegram - Financial Content
Oragenics Inc (AMEX:OGEN): It’s all about numbers this morning - US Post News
Closing Strong: Oragenics Inc (OGEN) Ends at 0.26, Down -9.26 from Last Close - The Dwinnex
Market Recap: Lexeo Therapeutics Inc (LXEO)’s Negative Momentum, Closing at 4.95 - The Dwinnex
Market Watch: Outset Medical Inc (OM)’s Noteworthy Gain, Closing at 0.81 - The Dwinnex
Oragenics, Inc. Chief Medical Officer to Speak at Brain Health SummitOn February 5, 2025, Oragenics, Inc. (NYSE American: OGEN) revealed through a press release that its Chief Medical Officer, James P. Kelly, MA, MD, FAAN, FANA, will be a prominent p - Defense World
Virpax Pharmaceuticals Appoints Charn Deol as Independent DirectorVirpax Pharmaceuticals, Inc. (NASDAQ:VRPX) announced on February 5, 2025, the appointment of Mr. Charn Deol as an independent director of the Company, effective immediately. Mr. D - Defense World
There is no way Arrowhead Pharmaceuticals Inc (ARWR) can keep these numbers up - SETE News
Views of Wall Street’s Leading Experts on Oragenics Inc - SETE News
Power Nickel's (TSX.V: PNPN) Hole Delivers "BIG"- Gold Terra - openPR
Power Nickel’s (TSX.V: PNPN) Hole Delivers “BIG”- Gold Terra (TSX.V: YGT) Developments and Exploration Progress Reported – More Stocks Inside! | FinancialContent Business Page - Financial Content
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
OGEN’s valuation metrics: A comprehensive analysis - US Post News
Unum Group to Present at the 2025 UBS Financial Services Conference - Yahoo Finance UK
In the Green: Oragenics Inc (OGEN) Closes at 0.28, Up/Down -2.34 from Previous Day - The Dwinnex
Closing Bell Recap: Merck & Co Inc (MRK) Ends at 90.74, Reflecting a -9.07 Downturn - The Dwinnex
Market Insights: 4D Molecular Therapeutics Inc (FDMT)’s Notable Drop of -0.17, Closing at 5.92 - The Dwinnex
Post-Trade Analysis: Charter Communications Inc (CHTR) Slides -0.36, Closing at 340.26 - The Dwinnex
US Stocks Mixed; Walt Disney Posts Upbeat Earnings - Benzinga
United Micro Electronics ADR [UMC] Investment Guide: What You Need to Know - Knox Daily
Oragenics Inc (OGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily
The Potential Rise in the Price of Dolby Laboratories Inc (DLB) following insiders activity - Knox Daily
Oragenics Inc Inc. (OGEN) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
PCSO Lotto Results | February 5, 2025 - The Manila Times
Oragenics, Inc. CMO James P. Kelly to Speak at 12th Annual Brain Health Summit During Super Bowl Weekend - Nasdaq
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025 - yourbigsky.com
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
Nisa Investment Advisors LLC Sells 121,826 Shares of Hudson Pacific Properties, Inc. (NYSE:HPP) - Defense World
Oragenics (NYSE:OGEN) Coverage Initiated at StockNews.com - Defense World
Rubicon Technology (NASDAQ:RBCN) Now Covered by StockNews.com - Defense World
BlackRock Long-Term Municipal Advantage Trust (NYSE:BTA) Enters Standstill Agreement with Saba Capital Management, L.P.On January 20, 2025, BlackRock Long-Term Municipal Advantage Trust (NYSE:BTA) disclosed that it, along with BlackRock Advis - Defense World
Avalon (NYSE:AWX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Oragenics, Inc. Update: Janet Huffman Appointed Interim CEO - Defense World
Credit Suisse Group (NYSE:CS) Now Covered by StockNews.com - Defense World
Dermata Therapeutics Signs Clinical Trial Collaboration Agreement with Revance Therapeutics for Topical Treatment StudyDermata Therapeutics, Inc. (NASDAQ: DRMA) revealed in an 8-K filing that on January 17, 2025, the company entered into a Clinical T - Defense World
Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) Shares Gap Down After Earnings Miss - Defense World
Oragenics (OGEN) Stock Price, News & Analysis - MarketBeat
Oragenics gears up for Phase II trials, appoints new CEO By Investing.com - Investing.com Australia
Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO - GlobeNewswire
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):